Publications

The publication of research results is a fundamental requirement for improving treatment concepts across the board. iOMEDICO supports the international guidelines on transparency and publication of medical research results.

We regularly present our data at national and international conferences. Our publications appear in scientifically renowned, international journals. Authors are principal investigators, investigators with a high number of participating patients, and iOMEDICO scientists.

TITEL
STUDIE
JAHR
Interim analysis of the German non-interventional post marketing surveillance study (NIS) on Quality of Life (QoL) of capecitabine in patients with metastatic breast cancer (MBC).

Zaiss, M., Fuxius, S., Lerchenmueller, C., Hahn, L., Luhn, B., Marschner, N., Steffens, C.C., Soeling, U., Mueller, V., 2010.

Ann Oncol 21 (suppl 8)(314P), viii108. doi:10.1093/annonc/mdq517

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: ESMO / Journal: Annals of Oncology
Xeloda-NIS
2010
Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries.

van Nes, J.G.H., Seynaeve, C., Jones, S., Markopoulos, C., Putter, H., van de Velde, C.J.H., Hasenburg, A., Rea, D.W., Vannetzel, J.-M., Dirix, L., Hozumi, Y., Kerin, M.J., Kieback, D.G., Meershoek-Klein Kranenbarg, W.M., Hille, E.T.M., Nortier, J.W.R., 2010.

Br J Surg 97, 671–679. doi:10.1002/bjs.6962

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: - / Journal: British Journal of Surgery
TEAM
2010
Trends in surgical treatment of breast cancer. Data from a clinical registry.

Tesch, H., Rauh, J., Fietz, T., Overkamp, F., Hartmann, H., Marschner, N., 2010.

Onkologie 33 (suppl 6)(P194), 54. doi:10.1159/000321407

Abstract

Download

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: DGHO / Journal: Onkologie
TMK
2010
HEXAFIL: Non-interventional study for supportive treatment of chemotherapy induced neutopenia with Filgrastim HEXAL®.

Tesch, H., Indorf, M., Hartmann, U., 2010.

Onkologie 33 (suppl 6)(P241), 71. doi:10.1159/000321409

Abstract

Indikation: Supportive Therapy, Supportivtherapie / Veranstaltung: DGHO / Journal: Onkologie
HEXAFIL
2010
Treatment of tumor induced iron deficiency with ferric carboxymaltose (FCM, ferinject®)

Steinmetz, T., Tschechne, B., Selak, E., Kellner, T., Schröder, D., Marschner, N., Virgin, G., Kaldeweier, A., 2010.

Onkologie 33 (suppl 6)(P250), 74. doi:10.1159/000321409

Abstract

Indikation: Supportive Therapy, Supportivtherapie / Veranstaltung: DGHO / Journal: Onkologie
Ferinject-NIS
2010
Tolerability of different first-line treatment (trt) regimens in patients (pts) with advanced or metastatic renal cell carcinoma (mRCC).

Müller, L., Münch, A., Blumenstengel, K., Hutzschenreuther, U., Busies, S., 2010.

J Clin Oncol 28(Sup. abstr e15086). doi: 10.1200/jco.2010.28.15_suppl.e15086

Abstract

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: ASCO / Journal: Journal of Clinical Oncology
TNK
2010
Physicians underestimate the severity of fatigue, stomatitis, HFS and dysgeusia in mRCC-patients on systemic therapy: Interimanalysis of the Fatigue, Mucositis, Hand-Foot-Syndrome, and Dysgeusia in RCC study (FAMOUS).

Marschner, N., Münch, A., Lerchenmüller, C., Linz, B., Müller, L., 2010.

Onkologie 33 (suppl 6)(P203), 58. doi:10.1159/000321407

Abstract

Download

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: DGHO / Journal: Onkologie
TNK
2010
Impact of adverse drug reactions (ADR) on systemic therapy in patients (pts) with advanced or metastatic renal cell carcinoma (mRCC).

Marschner, N., Münch, A., Blumenstengel, K., Sauer, U., Müller, L., 2010.

Ann Oncol, Abstract 949 21(suppl 8), viii298. doi:10.1093/annonc/mdq525

Abstract

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: ESMO / Journal: Annals of Oncology
TNK
2010
Epidemiologisches Register zur Darstellung der Behandlungsrealität und der Therapiemodalitäten beim behandlungsbedürftigen metastasierten oder lokal fortgeschrittenen Nierenzellkarzinom.

Marschner, N., Müller, L., 2010.

Presented at the 29. Deutscher Krebskongress (DKK), Berlin.

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: DKK / Journal: -
TNK
2010
Klinische Tumorregister als Instrument der Versorgungsforschung: Das Netzwerk der niedergelassenen Hämatologen und Onkologen.

Marschner, N., Jänicke, M., 2010.

Remission, 3, 3–5.

Indikation: Other, Sonstige / Veranstaltung: - / Journal: Remission
Registerübergreifend
2010